Literature DB >> 32253424

The role of human cytomegalovirus in atherosclerosis: a systematic review.

Wenbo Zhu1, Shuangquan Liu2.   

Abstract

Atherosclerosis is a progressive vascular disease with increasing morbidity and mortality year by year in modern society. Human cytomegalovirus (HCMV) infection is closely associated with the development of atherosclerosis. HCMV infection may accelerate graft atherosclerosis and the development of transplant vasculopathy in organ transplantation. However, our current understanding of HCMV-associated atherosclerosis remains limited and is mainly based on clinical observations. The underlying mechanism of the involvement of HCMV infection in atherogenesis remains unclear. Here, we summarized current knowledge regarding the multiple influences of HCMV on a diverse range of infected cells, including vascular endothelial cells, vascular smooth muscle cells, monocytes, macrophages, and T cells. In addition, we described potential HCMV-induced molecular mechanisms, such as oxidative stress, endoplasmic reticulum stress, autophagy, lipid metabolism, and miRNA regulation, which are involved in the development of HCMV-associated atherogenesis. Gaining an improved understanding of these mechanisms will facilitate the development of novel and effective therapeutic strategies for the treatment of HCMV-related cardiovascular disease.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  atherosclerosis; human cytomegalovirus; infection; mechanism

Mesh:

Substances:

Year:  2020        PMID: 32253424     DOI: 10.1093/abbs/gmaa005

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  7 in total

Review 1.  Human cytomegalovirus (HCMV)-encoded microRNAs: potential biomarkers and clinical applications.

Authors:  Raquel Fernández-Moreno; Julián Torre-Cisneros; Sara Cantisán
Journal:  RNA Biol       Date:  2021-05-26       Impact factor: 4.766

2.  Vitamin D3 Suppresses Human Cytomegalovirus-Induced Vascular Endothelial Apoptosis via Rectification of Paradoxical m6A Modification of Mitochondrial Calcium Uniporter mRNA, Which Is Regulated by METTL3 and YTHDF3.

Authors:  Wenbo Zhu; Hongbo Zhang; Shao Wang
Journal:  Front Microbiol       Date:  2022-03-11       Impact factor: 5.640

3.  IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection.

Authors:  Gloria Griffante; Weronika Hewelt-Belka; Camilla Albano; Francesca Gugliesi; Selina Pasquero; Sergio Fernando Castillo Pacheco; Greta Bajetto; Paolo Ettore Porporato; Erica Mina; Marta Vallino; Christian Krapp; Martin Roelsgaard Jakobsen; John Purdy; Jens von Einem; Santo Landolfo; Valentina Dell'Oste; Matteo Biolatti
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

Review 4.  The Role of CMV Infection in Primary Lesions, Development and Clinical Expression of Atherosclerosis.

Authors:  Carmen Valentina Cristescu; Sophie Alain; Simona Maria Ruță
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

5.  Genetic Predisposition of Anti-Cytomegalovirus Immunoglobulin G Levels and the Risk of 9 Cardiovascular Diseases.

Authors:  Jiang-Shan Tan; Jia-Meng Ren; Luyun Fan; Yuhao Wei; Song Hu; Sheng-Song Zhu; Yanmin Yang; Jun Cai
Journal:  Front Cell Infect Microbiol       Date:  2022-06-27       Impact factor: 6.073

Review 6.  Immunosenescence in atherosclerosis: A role for chronic viral infections.

Authors:  Atefe Ghamar Talepoor; Mehrnoosh Doroudchi
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

7.  Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells.

Authors:  Sven Seitz; Anna Theresa Heusel; Thomas Stamminger; Myriam Scherer
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.